Meetings, Conferences, & Workshops (Drugs)

The following are meetings, conferences, and workshops sponsored by the Center for Drug Evaluation and Research (CDER):

Upcoming

• DIA/FDA Assessing Benefits and Risks of Medicinal Products in Regulatory Decisions, November 3-5, 2009, Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland. Meeting information and registration
• IABS/FDA co-sponsored Scientific Conference:  Protein Particles and Immunogenicity of Therapeutic Proteins: Filling in the Gaps in Risk Evaluation and Mitigation.  November 12-13, 2009, Bethesda, MD. Meeting and Registration Information.  Meeting Brochure (PDF - 171 KB)
• Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools, November 12 and 13, 2009 Meeting information Registration for this meeting is closed. Please see meeting information for webcast instructions.
• Indexing Labeling for Human Drug and Biological Products using Structured Product Labeling (SPL). February 2010.
• DIA/FDA CDER/CBER Computational Science Annual Meeting, March 22-23, 2010,  Bethesda, MD. Meeting information and registration.
• 4th Annual FDA/DIA Statistics Forum, April 19-21, 2010, Bethesda, MD. Meeting information and registration.

 

Past

• DIA/FDA/PhRMA Modeling and Simulation in Drug Development: Quantitative Approaches for Decision Making, October 28-29, 2009, Marriott Bethesda Pooks Hill, 5151 Pooks Hill Road, Bethesda, Maryland. Meeting information and registration
• CDER's Small Business Assistance Educational Forum: The Investigational New Drug Process, Public Workshop, October 15, 2009, 5100 Paint Branch Parkway, College Park, MD 20740. Auditorium 1A003. Meeting information and registration
• Preparation for ICH meetings in St. Louis, Missouri to provide information and receive comments on the International Conference on Harmonization (ICH) as well as the upcoming meetings in St. Louis, Missouri, Public Meeting, October 14, 2009, Washington Room, Hilton Rockville, 1750 Rockville Pike, Rockville, Maryland
• DIA/FDA/NCI/PhRMA Progression-Free Survival Oncology Workshop, October 7-9, 2009, DoubleTree Hotel and Executive Meeting Center, 8120 Wisconsin Avenue, Bethesda, Maryland 20814. Meeting information and registration
• CDER Forum for International Drug Regulatory Authorities, October 5-9, 2009, Silver Spring, Maryland.
• Educating the Public About Removal of Essential-Use Designation for Epinephrine, Public Workshop, September 25, 2009, FDA, Center for Drug Evaluation and Research Advisory Committee Conference Room, 5600 Fishers Lane, Rm 1066, Rockville, Maryland 20852
• Providing Effective Information to Consumers about Prescription Drug Risks and Benefits; Public Workshop, September 24-25, 2009, Gaithersburg, MD 20877. Meeting information
• Drug Information Association (DIA) and Food and Drug Administration (FDA): Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications: Current State of the Art and Opportunities to Advance the Science, September 23-24, 2009, Omni Shoreham Hotel, Washington, D.C. Meeting information and registration
• FDA, Issues in the Development of Antiviral Products for Treatment of Smallpox and Related Poxvirus Infections; Public Workshop, September 1-2, 2009
• Issues in the Design of Clinical Trials of Antimycobacterial Drugs for Treatment of Tuberculosis; Public Workshop, July 29, 2009 and July 30, 2009, Silver Spring, Maryland.  Meeting Information
• 2009 PDA/FDA Asia-Pacific Pharmaceutical Ingredient Supply Chain Conference, June 15-19, 2009, Shanghai, China. Meeting Information and registration
• Quality Risk Management – Implementation Strategies; US FDA/CDER and University of Rhode Island College of Pharmacy Conference, June 15-16, 2009, Hyatt Regency Bethesda, Bethesda, Maryland. Meeting Information.
• Applied Biopharmaceutics and Quality by Design for Dissolution/Release Specification Setting: Product Quality for Patient Benefit, June 10-12, 2009, Hilton Washington DC/Rockville 1750 Rockville Pike, Rockville, MD.  Meeting Information
• Public Workshop on Developing a Consolidated Pediatric Rheumatology Observational Registry, May 12-13, 2009.  Meeting Information
• Propylthiouracyl (PTU)-Related Liver Toxicity; Public Workshop; April 18, 2009, Washington, DC.  Meeting Information
• Clinical Trial Design for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia; Public Workshop, March 31, 2009 and April 1, 2009, Silver Spring, Maryland.  Meeting Information
• PQRI Workshop: Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products, March 9-10, 2009, Hyatt Regency Bethesda, Bethesda, MD. Program and registration
•  Clinical Trial Design for Community-Acquired Pneumonia; Public Workshop, January 17-18, 2008, Silver Spring, Maryland. Meeting Information